📝 Executive Summary
Hyperliquid traders value Unitree at nearly $38 billion versus $9 billion at its IPO, leaving leveraged bets vulnerable when trading begins, Allium analysts said.
Bearish
🤖 85%
Unitree's pre-IPO valuation on Hyperliquid is $38 billion, four times the IPO price of $9 billion. Allium analysts flag that leveraged positions built on this premium are exposed to a sharp repricing when shares start trading. The gap signals speculative excess in the crypto-native pre-IPO market.
Catalysts
- ▼ Hyperliquid pre-IPO market prices Unitree at $38 billion
- ▼ Unitree IPO priced at $9 billion
Risk Factors
- ▲ Post-IPO demand exceeds $38 billion valuation
- ▲ Hyperliquid market illiquidity distorts price signals
▼ Show FAQ (3) ▲ Hide FAQ
Why is Unitree's pre-IPO valuation on Hyperliquid four times its IPO price?
Hyperliquid traders are placing leveraged bullish bets expecting significant upside after the company lists. The pre-IPO market allows speculative positioning before the official shares trade, driving the valuation to $38B versus the $9B IPO price.
What happens to leveraged Unitree bets if the stock trades below $38B after IPO?
Allium analysts warn those positions are vulnerable to liquidation if the public market does not support the pre-IPO valuation, potentially triggering sharp drawdowns.
Should investors buy Unitree at the IPO price or wait?
The article does not provide direct advice, but the 4x premium on Hyperliquid suggests the pre-IPO market expects strong early gains; however, leverage adds risk that could create buying opportunities post-listing.